Metastatic colorectal cancer (mCRC) remains a daunting challenge, especially after first-line treatments fail.
Dual-antibody therapy shows promise in treating metastatic colorectal cancer
- Post author:
- Post published:December 8, 2024
- Post category:uncategorized
- Post comments:0 Comments